YR Media Launches Season Two of Inherited Podcast, Shining a Spotlight on Youth Climate Storytellers and Activists

Featuring BIPOC youth storytellers from around the globe, climate change-focused podcast now available through YR Media and Critical Frequency across all major platforms OAKLAND, Calif.–(BUSINESS WIRE)–#YRMedia—Inherited, the widely acclaimed youth climate movement storytelling podcast, is back for an all-new season, featuring a fresh lineup of powerful and personal stories from young people, particularly from historically … [Read more…]

Amylyx Pharmaceuticals Announces Donated CENTAUR Clinical Trial Data Now Available to Help Advance Science in ALS for Future Treatments and Discoveries

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. today announced that the donated clinical data from the placebo arm of the CENTAUR clinical trial that evaluated the safety, efficacy, and survival benefits of AMX0035 in adult participants with amyotrophic lateral sclerosis (ALS) are now available in the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) database. The PRO-ACT project … [Read more…]

Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Technology Awards

Achievers and Quest Diagnostics secure the Gold award for Best Advance in Employee Recognition Program in the Talent Management category TORONTO–(BUSINESS WIRE)–#EmployeeExperience–Achievers, an industry-leading employee experience software platform, announces its joint win of a Gold award by Brandon Hall Group with its customer case study of Quest Diagnostics (NYSE: DGX), the world’s leading provider of … [Read more…]

Veradigm and Vytalize Health: Paving the Way for Primary Care Physicians to Improve Patient Outcomes

Value-based care is here to stay; the Veradigm Network is at the forefront of supporting healthcare providers to improve patient outcomes today and in the future CHICAGO–(BUSINESS WIRE)–$MDRX #healthIT–Veradigm®, a leading provider of healthcare data and technology solutions and a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), and Vytalize Health, a new kind of … [Read more…]

Aldeyra Therapeutics Announces Positive Dry Eye Disease Pre-NDA Meeting with the FDA and Highlights Upcoming Corporate Milestones

Dry Eye Disease NDA for Reproxalap Expected to be Submitted in the Fourth Quarter of 2022 Pre-NDA Meeting for ADX-2191 for the Treatment of Primary Vitreoretinal Lymphoma Scheduled for the Fourth Quarter of 2022 Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy Expected in the Third or Fourth … [Read more…]

Global Genes Honors a Diverse Group of International Rare Disease Leaders at the 2022 RARE Champions of Hope Celebration

ALISO VIEJO, Calif.–(BUSINESS WIRE)–Global Genes, a leading rare disease patient advocacy organization, today announced its annual RARE Champions of Hope award winners, recognizing leaders and organizations for their inspiring work in driving innovation, advocacy and change in rare disease as part of the 2022 RARE Disease Patient Advocacy Summit in San Diego. This year, the … [Read more…]

IconOVir Bio to Present at UBS Biotechnology Virtual Private Company Symposium

SAN DIEGO–(BUSINESS WIRE)–IconOVir Bio, Inc. (IconOVir), a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus (OV) therapy to improve the treatment of patients with cancer, today announced that Mark McCamish, M.D., Ph.D., President and Chief Executive Officer of IconOVir, will present a corporate overview at the UBS Biotechnology Virtual Private Company Symposium on … [Read more…]

NextGen Healthcare Announces New Foster Care Functionality in Behavioral Health Suite

New features round out human services offering in industry’s only comprehensive EHR platform to encompass physical, dental and behavioral health ATLANTA–(BUSINESS WIRE)–$NXGN #NextGenHealthcare–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced the newest release of its NextGen® Behavioral Health Suite. Built upon the company’s award-winning NextGen® Enterprise electronic … [Read more…]

CareDx Celebrates 1 Million Organ Transplants and 100,000 Patient Milestone

One out of Ten Patients Served by CareDx Signals Broad Uptake of Company’s Non-Invasive Testing Services for Heart, Kidney, and Lung Transplant Patients BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that … [Read more…]

OncoNano Medicine Announces Oral Presentation of Phase 2 Study Data at the World Molecular Imaging Congress 2022

SOUTHLAKE, Texas–(BUSINESS WIRE)–OncoNano Medicine, Inc. today announced a presentation of data from its ongoing Phase 2 study of pegsitacianine at the World Molecular Imaging Congress (WMIC), occurring September 27 – October 1, 2022. The presentation will be given during the Cancer: Innovations in Molecular Imaging session. Details of the oral presentation are as follows: Presentation … [Read more…]